← SynDRA
OLPRINONE
SynDRA canonical compound SYN0025352 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | PDE3A |
|---|
| Mechanism of action | Phosphodiesterase inhibitor |
|---|
| Indication | congestive heart failure |
|---|
| Disease area | cardiology |
|---|
All known targets
- PDE3A
- PDE3B
- PDE4A
- PDE4B
- PDE4C
- PDE4D
Mechanisms of action (all sources)
- Phosphodiesterase inhibitor
- PDE3B INHIBITOR
- PDE3A INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- OPRM1
- HTR1A
- HTR2B
- KCNH2
- KDR
- MAOA
- MPHOSPH8
- NFKB1
- PGR
- ADORA3
- PMP22
- POLH
- PTGS1
- RGS4
- SLC6A2
- SLC6A3
- SLC6A4
- HSD17B10
- HRH3
- HPGD
- HDAC6
- ADRA1A
- ADRA2A
- AR
- ATAD5
- ATXN2
- BLM
- CBX1
- CHRM1
- CHRM2
- CYP3A4
- DRD1
- DRD3
- EHMT2
- ESR1
- F2
- TBXA2R
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- COMT
- GAMT
- GNMT
- HNMT
- NNMT
- NTM1A
- PNMT
- TP53
Drug classes
- Cardiotonic Agents
- Cardiovascular Agents
- Enzyme Inhibitors
- Phosphodiesterase 3 Inhibitors
- Phosphodiesterase Inhibitors
- Protective Agents
Cross-references
Synonyms
- E-1020
- olprinone hydrochloride
- olprinone hydrochloride hydrate
- loprinone
- olprinone HCl
- Olprinona
- Loprinone
- Coretec
- Olprinone [INN]
- UNII-4Y8BMI9YGC
- 4Y8BMI9YGC
- C14H10N4O
- Olprinone (INN)
- 5-imidazo[1,2-a]pyridin-6-yl-6-methyl-2-oxo-1H-pyridine-3-carbonitrile
- 1,2-Dihydro-5-imidazo(1,2-alpha)pyridin-6-yl-6-methyl-2-oxonicotinonitrile
- 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridinecarbonitrile
- AC1L1IIG
- AC1Q4Q1U
- SCHEMBL27661
- DTXSID1048461
- CHEMBL1474900
- KS-00000EYK
- MolPort-006-394-808
- JPAWFIIYTJQOKW-UHFFFAOYSA-N
- CHEBI:135019
- BCP09781
- ZINC38192538
- HY-14254A
- 3950AH
- olprinona
- olprinonum
- RefChem:168173
- DTXCID7028435
- MFCD25541649
- LOPRINONE [MI]
- OLPRINONE [WHO-DD]
- orb1302152
- GLXC-07825
Look up OLPRINONE in the interactive SynDRA portal →